Jnana Therapeutics Presents New Positive Data from Phase 1/2 Study of JNT-517 in Individuals with Phenylketonuria – Results Support Planned Pivotal Study in Early 2025
04. September 2024 07:30 ET
|
Jnana Therapeutics, Inc.
Jnana Therapeutics presents new positive data at SSIEM 2024 from Phase 1/2 study of JNT-517 in individuals with phenylketonuria (PKU).
Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc.
01. August 2024 00:01 ET
|
Jnana Therapeutics, Inc.
Otsuka Pharmaceutical to acquire Jnana Therapeutics Inc.
Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
08. Mai 2024 08:00 ET
|
Jnana Therapeutics, Inc.
Jnana CEO Joanne Kotz will present a corporate overview at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024 at 2:05 p.m. ET.
Jnana Therapeutics to Participate in Upcoming Investor Conferences
27. Februar 2024 08:00 ET
|
Jnana Therapeutics, Inc.
BOSTON, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for...
Jnana Therapeutics Announces Positive Clinical Proof of Concept Achieved with JNT-517, a Potential First-in-Class Oral Treatment for PKU
30. Januar 2024 08:15 ET
|
Jnana Therapeutics, Inc.
Jnana Therapeutics announces positive, statistically significant interim results from its ongoing clinical study of JNT-517 in individuals with PKU.
Jnana Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
04. Januar 2024 08:00 ET
|
Jnana Therapeutics, Inc.
Jnana Therapeutics CEO Joanne Kotz, PhD, will present at the J.P. Morgan Healthcare Conference on Monday, January 8, at 5:30pm PT.
Jnana Therapeutics to Present at the RBC Capital Markets Healthcare Private Company Virtual Conference
06. Dezember 2023 08:00 ET
|
Jnana Therapeutics, Inc.
Jnana Therapeutics CEO Joanne Kotz will participate in a fireside chat on Dec. 13 at the RBC Capital Markets Healthcare Private Company Conference.
Jnana Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
21. November 2023 08:00 ET
|
Jnana Therapeutics, Inc.
Jnana Therapeutics CEO Joanne Kotz, Ph.D., will present a corporate overview at the Piper Sandler 35th Annual Healthcare Conference.
Jnana Therapeutics to Participate in Upcoming Investor Conferences
05. Oktober 2023 08:00 ET
|
Jnana Therapeutics, Inc.
BOSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets,...
Jnana Therapeutics to Participate in Upcoming Investor Conferences
06. September 2023 08:00 ET
|
Jnana Therapeutics, Inc.
BOSTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets,...